A Rocket Pharmaceuticals gene therapy has landed a long-awaited FDA approval, bringing a new treatment option to patients with a certain inherited immunodeficiency so severe that many babies do not …
Category:
Health
-
-
Everlywell, an at-home lab testing company, is partnering with AI-powered gut microbiome company Jona to bring a gut microbiome test to consumers nationwide. Everlywell is a direct-to-consumer company selling tests …
-
Health systems should use data to identify problems before buying AI tools, according to Arcadia CEO Michael Meucci. The market is flooded with vendors pitching AI solutions — but instead …
-
The pressure facing healthcare leaders has never been higher, from workforce challenges and Medicaid cuts to rising tariff uncertainty. In fact, under the One Big Beautiful Bill Act (OBBBA), tens …
-
They’re a great way to bring screenings, diagnostics and preventive care services to the people who need them. However, launching a mobile clinic program requires a partner that understands medical …
-
Health
Democratizing Access: How Community Hospitals Can Drive the Next Wave of Robotic Bronchoscopy
For years, robotic bronchoscopy was confined mainly to elite academic centers and referral hospitals that possessed the budgets, staffing, and infrastructure required to support early-generation systems. That era is ending. …
-
Millions of Americans are struggling to access physical and behavioral healthcare, and providers across the country are overworked, understaffed and face significant economic pressure. Nonetheless, they are expected to innovate …
-
The Department of Justice filed an antitrust lawsuit against NewYork-Presbyterian Hospital this week, alleging the provider used restrictive payer contracts to block lower-cost plans. The agency claims the health system …
-
UnitedHealthcare launched a generative AI companion on Thursday called Avery, which aims to improve care coordination for members. Avery can support members with a variety of issues like coverage and …
-
Cancer drug research continues to bring patients targeted therapies for tumors that express specific genetic or biological signatures. This precision oncology approach means a clinician can tailor treatment to a …